Abstract
Background Age-related hearing loss is a common, heterogeneous disease with a strong genetic component. More than 100 loci have been reported to be involved in human hearing impairment to date, but most of the genes underlying human adult-onset hearing loss remain unknown. Most genetic studies have focussed on very rare variants (such as family studies and patient cohort screens) or very common variants (genome-wide association studies). However, the contribution of variants present in the human population at intermediate frequencies is hard to quantify using these methods, and as a result, the landscape of variation associated with adult-onset hearing loss remains largely unknown.
Results Here we present a study based on exome sequencing and self-reported hearing difficulty in the UK Biobank, a large-scale biomedical database. We have carried out variant load analyses using different minor allele frequency and impact filters, and compared the resulting gene lists to a manually-curated list of nearly 700 genes known to be involved in hearing in humans and/or mice. An allele frequency cutoff of 0.1, combined with a high predicted variant impact, was found to be the most effective filter settings for our analysis. We also found that separating the participants by sex produced markedly different gene lists. The gene lists obtained were investigated using gene ontology annotation, functional prioritisation and expression analysis, and this identified good candidates for further study.
Conclusions Our results suggest that relatively common as well as rare variants with a high predicted impact contribute to age-related hearing impairment, and that the genetic contributions to adult hearing difficulty may differ between the sexes. Our manually-curated list of deafness genes is a useful resource for candidate gene prioritisation in hearing loss.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the National Institutes of Health/National Institute on Deafness and Other Communication Disorders (NIH/NIDCD, grant number P50 DC 000422) and the National Institute for Health Research (NIHR) Biomedical Research Centre, King's College London.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The North West Multi-centre Research Ethics Committee (MREC) gave ethical approval for the UK Biobank to operate as a Research Tissue Bank, which means that individual researchers using UK Biobank data do not need separate ethical clearance. Please see https://www.ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us/ethics, which has links to the current approval (renewed in 2021).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This version of the manuscript has been revised to correct errors and include new analyses.
Data Availability
All UK Biobank data, including the exome sequence data and questionnaire data used in this study, is publicly available to registered researchers through the UK Biobank data access protocol. Further information about registration may be found at http://www.ukbiobank.ac.uk/register-apply/. The mouse single cell RNAseq data used in this study is publicly available from the gEAR database at https://umgear.org.
